Literature DB >> 17546667

Mesoporous silicon in drug delivery applications.

Jarno Salonen1, Ann M Kaukonen, Jouni Hirvonen, Vesa-Pekka Lehto.   

Abstract

During the last few years, a number of interesting drug delivery applications of mesoporous materials have been demonstrated. Mesoporous silicon has many important properties advantageous to drug delivery applications. The small size of the pores confines the space of a drug and engages the effects of surface interactions of the drug molecules and the pore wall. The size of the pores and the surface chemistry of the pore walls may be easily changed and controlled. Depending on the size and the surface chemistry of the pores, increased or sustained release of the loaded drug can be obtained. Drug loading from a solution at room temperature enables the use of porous silicon (PSi) also with sensitive therapeutic compounds susceptible to degradation, like peptides and proteins. This article reviews the fabrication and chemical modifications of PSi for biomedical applications, and also the potential advantages of PSi in drug delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17546667     DOI: 10.1002/jps.20999

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  73 in total

1.  Comparison of oxidized porous silicon with bare porous silicon as a photothermal agent for cancer cell destruction based on in vitro cell test results.

Authors:  Chongmu Lee; Chanseok Hong; Jungkeun Lee; Mikwon Son; Soon-Sun Hong
Journal:  Lasers Med Sci       Date:  2011-12-08       Impact factor: 3.161

2.  Sustained Release of a Monoclonal Antibody from Electrochemically Prepared Mesoporous Silicon Oxide.

Authors:  Jennifer S Andrew; Emily J Anglin; Elizabeth C Wu; Michelle Y Chen; Lingyun Cheng; William R Freeman; Michael J Sailor
Journal:  Adv Funct Mater       Date:  2010-09-08       Impact factor: 18.808

3.  Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.

Authors:  Miia Kovalainen; Juha Mönkäre; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto; Karl-Heinz Herzig; Kristiina Järvinen
Journal:  Pharm Res       Date:  2011-10-27       Impact factor: 4.200

4.  Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles.

Authors:  Jessica Méndez; Alina Monteagudo; Kai Griebenow
Journal:  Bioconjug Chem       Date:  2012-03-13       Impact factor: 4.774

5.  Mitotic trafficking of silicon microparticles.

Authors:  Rita E Serda; Silvia Ferrati; Biana Godin; Ennio Tasciotti; XueWu Liu; Mauro Ferrari
Journal:  Nanoscale       Date:  2009-10-05       Impact factor: 7.790

Review 6.  Bridging the divide between human and environmental nanotoxicology.

Authors:  Anzhela Malysheva; Enzo Lombi; Nicolas H Voelcker
Journal:  Nat Nanotechnol       Date:  2015-10       Impact factor: 39.213

7.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications.

Authors:  Ji-Ho Park; Luo Gu; Geoffrey von Maltzahn; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Nat Mater       Date:  2009-02-22       Impact factor: 43.841

8.  Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system.

Authors:  Jay Chhablani; Alejandra Nieto; Huiyuan Hou; Elizabeth C Wu; William R Freeman; Michael J Sailor; Lingyun Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

9.  Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice.

Authors:  Biana Godin; Ciro Chiappini; Srimeenakshi Srinivasan; Jenolyn F Alexander; Kenji Yokoi; Mauro Ferrari; Paolo Decuzzi; Xuewu Liu
Journal:  Adv Funct Mater       Date:  2012-10-23       Impact factor: 18.808

Review 10.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.